- PharmaBiome's NicheMap™ technology maps bacteria into functional niches taking into account the relevant complex context of intestinal microbiota
- The NicheMap™ provides an evidence-based selection rationale for strains that make up out metabolically interacting LBP consortia
- We produce these ecologically engineered consortia using cocultivation with PharmaBiome's C3 technology
- The NicheMap™ and C3 produce consortia with strong control over pharmacokinetics and pharmacodynamics
CSO
PharmaBiome
- Discussing the application of in-silico simulation (CarbonMirror Platform) to bioprocessing
- Understanding the limitations and benefits of in-silico simulation, choosing the optimum conditions for maximum yield and tackling biofilms
Nik Sharma
Chief Executive Officer
BioCortex
Jay Prakash
CEO and Co-Founder
Silence Laboratories
Oliver Weisser
Director, Commercial Operations
Ginkgo Bioworks
Jacquelin Gaulin
Founder
Gastro Girl Inc. and Host of Gastro Girl Podcast
Moreno Perugini
President Pharma
Nestle Health Sciences
Bertrand Foing
Founder & CEO
Secretarium & Klave
Bertrand Foing is the founder and CEO of Secretarium. He started his career in 2008 at Société Générale on the structured credit derivatives trading desk. He delivered both super-scalable, real-time solutions using tens of thousands of machines, and a series of high-performance tools for trading. Bertrand joined Société Générale’s Crypto and Blockchain Lab in 2014 and gained a deep understanding of trustless systems and privacy-enhancing technologies. He created Secretarium in 2016 to focus on privacy-preserving/confidential computing. With the help of the co-founder Cédric Wahl, they have achieved great success with major international institutions, and delivered an easy-to-adopt confidential computing platform, Klave, in 2023.